Business Description
GKB Ophthalmics Ltd
ISIN : INE265D01015
Description
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 1.4 | |||||
Equity-to-Asset | 0.48 | |||||
Debt-to-Equity | 0.21 | |||||
Debt-to-EBITDA | 8.33 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 1.68 | |||||
Beneish M-Score | -2.75 | |||||
WACC vs ROIC |
Growth Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 16.1 | |||||
3-Year EBITDA Growth Rate | -23.4 | |||||
3-Year EPS without NRI Growth Rate | -197.6 | |||||
3-Year FCF Growth Rate | 60 | |||||
3-Year Book Growth Rate | -1.6 |
Momentum Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 44.73 | |||||
9-Day RSI | 46.44 | |||||
14-Day RSI | 46.86 | |||||
6-1 Month Momentum % | -5.86 | |||||
12-1 Month Momentum % | -3.89 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.77 | |||||
Quick Ratio | 0.95 | |||||
Cash Ratio | 0.32 | |||||
Days Inventory | 223.52 | |||||
Days Sales Outstanding | 103.03 | |||||
Days Payable | 178.39 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shareholder Yield % | -1.43 |
Profitability Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 28.81 | |||||
Operating Margin % | -2.51 | |||||
Net Margin % | -3.72 | |||||
FCF Margin % | 2.19 | |||||
ROE % | -6.06 | |||||
ROA % | -3.13 | |||||
ROIC % | -4.21 | |||||
ROC (Joel Greenblatt) % | -2.63 | |||||
ROCE % | -2.16 | |||||
Years of Profitability over Past 10-Year | 4 |
GF Value Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shiller PE Ratio | 136.62 | |||||
PS Ratio | 0.51 | |||||
PB Ratio | 0.87 | |||||
Price-to-Tangible-Book | 0.86 | |||||
Price-to-Free-Cash-Flow | 23.34 | |||||
Price-to-Operating-Cash-Flow | 11.86 | |||||
EV-to-EBIT | -33.52 | |||||
EV-to-EBITDA | 33.7 | |||||
EV-to-Revenue | 0.51 | |||||
EV-to-FCF | 20.88 | |||||
Price-to-Projected-FCF | 1.86 | |||||
Price-to-Net-Current-Asset-Value | 1.6 | |||||
Earnings Yield (Greenblatt) % | -2.99 | |||||
FCF Yield % | 4.28 | |||||
Forward Rate of Return (Yacktman) % | -7.99 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
GKB Ophthalmics Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ₹) | 977.548 | ||
EPS (TTM) (₹) | -7.21 | ||
Beta | -0.34 | ||
Volatility % | 54.47 | ||
14-Day RSI | 46.86 | ||
14-Day ATR (₹) | 4.479785 | ||
20-Day SMA (₹) | 99.741 | ||
12-1 Month Momentum % | -3.89 | ||
52-Week Range (₹) | 74.1 - 136.4 | ||
Shares Outstanding (Mil) | 5.04 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
GKB Ophthalmics Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
GKB Ophthalmics Ltd Stock Events
Event | Date | Price(₹) | ||
---|---|---|---|---|
No Event Data |
GKB Ophthalmics Ltd Frequently Asked Questions
What is GKB Ophthalmics Ltd(BOM:533212)'s stock price today?
When is next earnings date of GKB Ophthalmics Ltd(BOM:533212)?
Does GKB Ophthalmics Ltd(BOM:533212) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |